UNIVERSITY OF TEXAS AT AUSTIN IMAGE: TENECTEPLASE WORKS FASTER, LEADS TO BETTER OUTCOMES & COSTS ABOUT $2500 LESS PER PATIENT, ACCORDING TO NEW DELL MED STUDY. CREDIT: DELL MEDICAL SCHOOL A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according...
by University of Texas at Austin Tenecteplase works faster, leads to better outcomes & costs about $2500 less per patient, according to new Dell Med study. Credit: Dell Medical School A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according...
by UT Southwestern Medical Center Credit: CC0 Public Domain Stroke patients on long-term blood thinners who were given the clot-busting drug alteplase enjoyed better recoveries than those who did not receive the drug and had no increased risk of bleeding, a new study led by UTSW researchers shows. The results run counter to the common...
